Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 380 participants.
Also called NCT07249853
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 380 participants
- Sponsor
- Registry
-
NCT07249853
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07249853. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-06 (actual); primary completion 2027-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage
- Acronym
- CAPTAIN
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug)
- Cilostazol 100 mg BID
- Intervention (Drug)
- placebo
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07249853- Content hash
042304700628d7705458abca74e2c33a7f937e3df7ceac861e760a6d29b28da0